CRISPR screens establish regulatory maps of immunosuppressive surface molecules in cancer
Robert Kalis, Sumit Deswal, Markus Schäfer, Mathias Kalxdorf, Julian Jude, Jesse Lipp, Sarah Rieser, Vivien Vogt, Melanie de Almeida, Michaela Fellner, Stefanie Ruhland, Lisa Frasz, Florian Andersch, Jeroen Krijgsveld, Sebastian Carotta, Johannes A. Zuber
The paper uses CRISPR screens to identify regulators of immunosuppressive surface molecules in cancer cells, finding DNAJC13 as a key regulator that enhances T-cell sensitivity and tumor survival.
bioRxiv · Mar 11, 2026 · PreprintMolecular Biology